JP2004530721A5 - - Google Patents

Download PDF

Info

Publication number
JP2004530721A5
JP2004530721A5 JP2003508341A JP2003508341A JP2004530721A5 JP 2004530721 A5 JP2004530721 A5 JP 2004530721A5 JP 2003508341 A JP2003508341 A JP 2003508341A JP 2003508341 A JP2003508341 A JP 2003508341A JP 2004530721 A5 JP2004530721 A5 JP 2004530721A5
Authority
JP
Japan
Prior art keywords
sustained release
pharmaceutically active
active ingredient
mini
implant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003508341A
Other languages
English (en)
Japanese (ja)
Other versions
JP4800570B2 (ja
JP2004530721A (ja
Filing date
Publication date
Priority claimed from AUPR6025A external-priority patent/AUPR602501A0/en
Application filed filed Critical
Publication of JP2004530721A publication Critical patent/JP2004530721A/ja
Publication of JP2004530721A5 publication Critical patent/JP2004530721A5/ja
Application granted granted Critical
Publication of JP4800570B2 publication Critical patent/JP4800570B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003508341A 2001-06-29 2002-07-01 徐放性医薬組成物 Expired - Fee Related JP4800570B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPR6025A AUPR602501A0 (en) 2001-06-29 2001-06-29 Sustained release pharmaceutical composition
AUPR6025 2001-06-29
PCT/AU2002/000865 WO2003002102A1 (en) 2001-06-29 2002-07-01 Sustained release pharmaceutical composition

Publications (3)

Publication Number Publication Date
JP2004530721A JP2004530721A (ja) 2004-10-07
JP2004530721A5 true JP2004530721A5 (cg-RX-API-DMAC7.html) 2005-12-22
JP4800570B2 JP4800570B2 (ja) 2011-10-26

Family

ID=3829991

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003508341A Expired - Fee Related JP4800570B2 (ja) 2001-06-29 2002-07-01 徐放性医薬組成物

Country Status (10)

Country Link
US (1) US20040241204A1 (cg-RX-API-DMAC7.html)
EP (1) EP1411904A4 (cg-RX-API-DMAC7.html)
JP (1) JP4800570B2 (cg-RX-API-DMAC7.html)
CN (1) CN1731988A (cg-RX-API-DMAC7.html)
AU (2) AUPR602501A0 (cg-RX-API-DMAC7.html)
BR (1) BR0210631A (cg-RX-API-DMAC7.html)
CA (1) CA2452030A1 (cg-RX-API-DMAC7.html)
CO (1) CO5540373A2 (cg-RX-API-DMAC7.html)
NZ (1) NZ529859A (cg-RX-API-DMAC7.html)
WO (1) WO2003002102A1 (cg-RX-API-DMAC7.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050129728A1 (en) * 2001-09-11 2005-06-16 Martinod Serge R. Sustained release pharmaceutical composition
CN1638747A (zh) * 2002-01-24 2005-07-13 斯玛特药物系统公司 持续释放药物组合物
BRPI0511694A (pt) * 2004-05-31 2008-01-08 Smart Drug Systems Inc composições de liberação controlada
JP2008502605A (ja) * 2004-06-16 2008-01-31 スマート ドラッグ システムズ インコーポレイティド 徐放性ワクチン組成物
AU2005253646B2 (en) * 2004-06-16 2011-09-15 Virbac Corporation Sustained release vaccine composition
ES2432556T3 (es) 2004-08-04 2013-12-04 Evonik Corporation Métodos para fabricar dispositivos de suministro y sus dispositivos
EP1859788A1 (en) * 2006-05-24 2007-11-28 Abbott GmbH & Co. KG Production of enveloped pharmaceutical dosage forms
NZ552290A (en) * 2006-12-21 2009-05-31 Bomac Research Ltd Tablet fomulation
BRPI0705822A2 (pt) * 2007-10-25 2009-06-23 Schering Plough Saude Animal Ltda formulação injetável com ação prolongada e uso de um agente semi-sintético derivado do grupo das avermectinas, em combinação com um polìmero biodegradável
EP2222281B1 (en) 2007-12-20 2018-12-05 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
JP5632851B2 (ja) * 2008-11-07 2014-11-26 コンビネント・バイオメデイカル・システムズ・インコーポレーテツド 疾患を処置および/若しくは予防するための装置および方法
CN102355891A (zh) 2009-03-17 2012-02-15 英特威国际有限公司 大环内酯药物递送系统
AU2011260260B2 (en) * 2010-06-01 2015-09-03 Baxter Healthcare S.A. Process for making dry and stable hemostatic compositions
PT2598151T (pt) * 2010-07-30 2019-04-15 Ceva Sante Animale Sa Composições para o tratamento da infestação por vermes do coração
JP5696279B2 (ja) * 2010-12-01 2015-04-08 学校法人自治医科大学 長期徐放型薬剤硬膜外腔留置システム
MX379693B (es) 2011-12-02 2025-03-11 Merial Ltd Formulaciones de moxidectina inyectables de larga acción y formas de cristal de moxidectina novedosas.
US20130190839A1 (en) * 2012-01-20 2013-07-25 Jane Rapsey Drug delivery using a sacrificial host
WO2014160026A2 (en) * 2013-03-14 2014-10-02 Endo Pharmaceuticals Solutions Inc. Implantable drug delivery compositions comprising sugar-based sorption enhancers and methods of treatment thereof
AU2013209343B1 (en) * 2013-05-14 2014-04-24 Activesignal Holding Limited Device for the Treatment of Bone Conditions
WO2016020901A1 (en) 2014-08-07 2016-02-11 Acerta Pharma B.V. Methods of treating cancers, immune and autoimmune diseases, and inflammatory diseases based on btk occupancy and btk resynthesis rate
ITUB20153652A1 (it) 2015-09-16 2017-03-16 Fatro Spa Microsfere contenenti lattoni macrociclici antielminitici
JP2021528452A (ja) * 2018-06-25 2021-10-21 タイタン ファーマシューティカルズ インコーポレイテッド インプラントとして使用するための装填可能な多孔質構造
US20220152044A1 (en) * 2019-03-14 2022-05-19 Palmaya Pty Ltd Treatment of inflammatory diseases of the central nervous system
CN110559431B (zh) * 2019-10-11 2023-02-28 南京农业大学 一种巨型艾美耳球虫纳米亚单位疫苗及其制备方法和应用
US11529310B2 (en) 2020-12-08 2022-12-20 Ruminant Biotech Corp Limited Devices and methods for delivery of substances to animals
US20240238226A1 (en) * 2021-03-09 2024-07-18 Adnan I. Qureshi Implantable sustained release device and a method of use thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3279996A (en) * 1962-08-28 1966-10-18 Jr David M Long Polysiloxane carrier for controlled release of drugs and other agents
US4053580A (en) * 1975-01-01 1977-10-11 G. D. Searle & Co. Microsealed pharmaceutical delivery device
US4331652A (en) * 1979-09-12 1982-05-25 Eli Lilly And Company Controlled release parasitic formulations and method
US4723958A (en) * 1986-05-23 1988-02-09 Merck & Co., Inc. Pulsatile drug delivery system
US5028430A (en) * 1987-05-08 1991-07-02 Syntex (U.S.A.) Inc. Delivery systems for the controlled administration of LHRH analogs
ATE90203T1 (de) * 1989-03-17 1993-06-15 Pitman Moore Inc Kontrollierte, verzoegerte wirkstofffreisetzung von makromolekularen proteinen.
ES2058923T3 (es) * 1989-06-21 1994-11-01 Univ Brown Res Found Sistema para terapia neurologica.
FR2653338B1 (fr) * 1989-10-23 1994-06-10 Dow Corning Sa Formulation pour des pansements a liberation prolongee de medicament et son utilisation.
JPH11508224A (ja) * 1990-08-09 1999-07-21 エンドコン・インコーポレーテッド 多重ドラッグデリバリーシステム
NZ239370A (en) * 1990-08-22 1994-04-27 Merck & Co Inc Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
US5211951A (en) * 1991-07-24 1993-05-18 Merck & Co., Inc. Process for the manufacture of bioerodible poly (orthoester)s and polyacetals
JPH06321803A (ja) * 1993-05-17 1994-11-22 Kirin Brewery Co Ltd 水溶性ペプチドホルモンの徐放性製剤
JP3720386B2 (ja) * 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
FR2745180B1 (fr) * 1996-02-23 1998-05-07 Dow Corning Sa Procede de fabrication de dispositifs a liberation controlee
EP1014970A1 (en) * 1997-09-23 2000-07-05 Pfizer Limited Parasiticidal formulations
AUPP279698A0 (en) * 1998-04-03 1998-04-30 Sunscape Developments Limited Sustained release formulation
WO2000003660A1 (en) * 1998-07-17 2000-01-27 Skyepharma, Inc. Biodegradable compositions for the controlled release of encapsulated substances
GB9816132D0 (en) * 1998-07-24 1998-09-23 Norbrook Lab Ltd Non-aqueous anthelmintic composition
WO2000013666A1 (en) * 1998-09-05 2000-03-16 Seung Jin Lee Biodegradable particulate polymeric preparation and process for producing thereof
US6645192B2 (en) * 1998-09-30 2003-11-11 Ivy Animal Health, Inc. Pellet implant system for immediate and delayed release of antiparasitic drug
AU6283299A (en) * 1998-10-01 2000-04-17 Elan Pharma International Limited Controlled release nanoparticulate compositions
CA2379909C (en) * 1999-08-06 2011-01-04 Board Of Regents, The University Of Texas System Drug releasing biodegradable fiber implant
TW524696B (en) * 1999-11-10 2003-03-21 Sumitomo Pharma Sustained-release drug formulations
WO2001037811A1 (en) * 1999-11-22 2001-05-31 Akzo Nobel N.V. Composition allowing predefined and controlled release of active ingredient, preparation thereof and use
US20020131988A1 (en) * 1999-12-16 2002-09-19 Foster Todd P. Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
US6998137B2 (en) * 2000-04-07 2006-02-14 Macromed, Inc. Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix

Similar Documents

Publication Publication Date Title
JP2004535473A5 (cg-RX-API-DMAC7.html)
JP4913321B2 (ja) 徐放性医薬組成物
EP0301856B1 (en) Delivery system
JP4459444B2 (ja) 多層構造を有する放出制御製剤
JP4800570B2 (ja) 徐放性医薬組成物
Ahmad et al. Gastro retentive drug delivery system: a review
JP2005505557A (ja) 持続放出医薬組成物の調製
JPWO1999062501A1 (ja) 多層構造を有する放出制御製剤
EP0981327A2 (en) Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors
JP2005523077A (ja) 抗肉芽腫剤を形成する特性を備えた胃瘻造設術又は空腸造瘻術に使用される薄型の組合せ装置
JP2003517014A (ja) 即放性および徐放性成分を含有する医薬インプラントおよび投与方法
AU2002344686A1 (en) Sustained release delivery system
JP7863276B2 (ja) 親油性又は両親媒性医薬物質の放出のためのインプラント
US20050118271A1 (en) Polytartrate composition
JP4753471B2 (ja) 長期薬物徐放性製剤
JP2005517653A5 (cg-RX-API-DMAC7.html)
US20050063907A1 (en) Radioopaque sustained release pharmaceutical system
AU2003201410B2 (en) Sustained release pharmaceutical composition
Cardinal et al. Drug delivery in veterinary medicine
Unde et al. Manoeuvring the innovative drug delivery systems for veterinary therapeutics: Present day demand
JPH09502182A (ja) 疎水性剤を含有するディスペンサー
AU2002344687A1 (en) Treatment of parasitic disease
WO1993017662A1 (en) Improved implants
WO1992018101A1 (en) Vaginal drug delivery device
Starr Innovations in drug delivery